ActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice.
ActX has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.
ActX's investors include Keiretsu Capital, Keiretsu Forum, Puget Sound Venture Club, Alliance of Angels.
ActX is headquartered in Seattle, United States.
ActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice.
ActX is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ActX — Funding & Investors." VCBacked, December 16, 2022, https://www.vcbacked.co/company/actx. Accessed August 14, 2026.
VCBacked. (2022). ActX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/actx
{{cite web |title=ActX — Funding & Investors |url=https://www.vcbacked.co/company/actx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated